U.S. Markets open in 8 hrs 43 mins

Wilson Disease: A Market Opportunity for Alexion

Sarah Collins
Wilson Disease: A Market Opportunity for Alexion

On April 11, 2018, Alexion Pharmaceuticals (ALXN) announced the acquisition of Wilson Therapeutics. Wilson Therapeutics is developing a drug to treat Wilson disease. Wilson disease is a rare genetic disorder that’s potentially life-threatening.